Susan is a distinguished biotech executive, entrepreneur and consultant committed to fostering innovation and growth in the cell and gene therapy industry. Susan has a proven executive management track record, with expertise in corporate governance, fundraising, and the establishment of strategic alliances. She is on the Phacilitate Advisory Board and on the Board of Directors for the Alliance for Regenerative Medicine.
We share insights from investors on what they prioritize when evaluating funding opportunities for cell and gene therapy tools.
